The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and ...

While Moderna isn’t looking to replace classical computing with quantum entirely, the company is interested in building a “quantum-enabled biotechnology pipeline.” In conjunction with IBM, the ...

There’s still plenty of room for growth as the AI race continues to unfold. Still, some growth investors are already moving ...

IBM and Moderna announced a new partnership today to explore the potential of generative AI and quantum computing. ... Garcia noted that Moderna is now part of the IBM Quantum Accelerator program, ...

Investment firms have issued research reports regarding IBM's earnings release, including RBC Capital, which raised its price ...

Moderna and IBM are joining forces to incorporate artificial intelligence (AI) and quantum computing into mRNA development, which was used to create Moderna’s COVID-19 vaccine. “We are … ...

Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicines Agreement with IBM includes investments in generative AI to ...

The biotechnology and pharmaceutical firm Moderna Inc., best known for its COVID-19 vaccine, said today it’s working with IBM Corp. to explore ways in which quantum computing and generative artifici ...

"We are excited to partner with IBM to develop novel AI models to advance mRNA science, prepare ourselves for the era of quantum computing, and ready our business for these game-changing technologies.

"IBM's purpose is to be the catalyst to make the world work better, perfectly exemplified by this partnership with Moderna. We are witnessing a revolution in the world of computing, driven by ...

Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicinesAgreement with IBM includes investments in generative AI to ...